Beste apotheek van Nederland

Foulks C J, Cushner H M. Sexual dysfunction in the male
dialysis patient: pathogenesis, evaluation, and therapy. [Review]
[105 refs]. Am J Kidney Dis 1986;8(4):211-222.
Frank T. Tadalafil (Cialis-Lilly). Consultant Pharmacist
2004;19(4):280-281.
Frank T. Vardenafil (Levitra-Bayer) GSK. Consultant
Pharmacist 2004;19(4):278-280.
Franzen D, Metha A, Seifert N et al. Effects of beta-blockers on
sexual performance in men with coronary heart disease. A
prospective, randomized and double blinded study. Int J Impot
Res 2001;13(6):348-351.
Fraunfelder F W, Fraunfelder F T. Scientific Challenges in
Postmarketing Surveillance of Ocular Adverse Drug Reactions.
Am J Ophthalmol 2007;143(1):
Freemantle N. Valuing the effects of sildenafil in erectile
dysfunction. Br Med J 2000;320(7243):1156-1157.
Freytag S O, Stricker H, Pegg J et al. Phase I Study of
Replication-Competent Adenovirus-Mediated Double-Suicide
Gene Therapy in Combination with Conventional-Dose Three-
Dimensional Conformal Radiation Therapy for the Treatment of
Newly Diagnosed, Intermediate- to High-Risk Prostate Cancer.
Cancer Res 2003;63(21):7497-7506.
Fu Q, Yao D-H, Jiang Y-Q. Effect of sodium nitroprusside on
hemodynamics of corpus cavernosum in Chinese. Asian J
Androl 2001;3(4):311-313.
Fugl-Meyer A R, Lodnert G, Branholm I B et al. On life
satisfaction in male erectile dysfunction. Int J Impot Res
1997;9(3):141-148.
Fulgram P F, Cochran J S, Denman J L et al. Re: Disappointing
initial results with transurethral alprostadil for erectile
dysfunction in a urology practice setting [5]. Br J Urol
1999;162(4):1390
Gallo L, Perdona S, Autorino R et al. Recovery of erection after
pelvic urologic surgery: our experience. Int J Impot Res
2005;17(6):484-493.
Gerstenbluth R E, Maniam P N, Corty E W et al. Prostatespecific
antigen changes in hypogonadal men treated with
testosterone replacement. J Androl 2002;23(6):922-926.
Ghezzi A, Malvestiti G M, Baldini S et al. Erectile impotence in
multiple sclerosis: A neurophysiological study. J Neurol
1995;242(3):123-126.
Giammusso B, Gattuso U, Vanaclocha V et al. Percutaneous
lumbar sympathectomy in the treatment of erectile dysfunction
secondary to cavernous adrenergic hypertone: initial results of
an original technique. Arch Ital Urol Androl 2005;77(1):5-9.
Giampietro O, Ferdeghini M, Cerri M et al. Evaluation of the
hypothalamic-pituitary-testicular interaction in diabetic males.
European J Lab Med 1994;2(2):83-89.
Gillies H C, Roblin D, Jackson G. Coronary and
systemic hemodynamic effects of sildenafil citrate:
From basic science to clinical studies in patients with
cardiovascular disease. Int J Cardiol 2002;86(2­
3):131-141.
Ginsberg D L. Gabapentin treatment of premature
ejaculation. Primary Psychiatry 2004;11(12):20-21.
Ginsberg D L. Vardenafil treatment of sertralineinduced
sexual dysfunction. Primary Psychiatry
2004;11(11):23-24.
Ginsberg David L. Sildenafil-dihydrocodeine
interaction results in prolonged erections.
[References]. Primary Psychiatry 2003;10(2):23
Ginzburg R, Wong Y, Fader J S. Effect of bupropion
on sexual dysfunction. Ann Pharmacother
2005;39(12):2096-2099.
Giuberti A, Picozzi S C, Mazza L et al. Testosterone
supplementation in hypogonadal men: our personal
experience. Arch Ital Urol Androl 2005;77(4):191­
193.
Giuliano F. Control of penile erection by the
melanocortinergic system: Experimental evidences
and therapeutic perspectives. J Androl
2004;25(5):683-691.
Giuliano F, Allard J, Rampin O et al. Pro-erectile
effect of systemic apomorphine: Existence of a spinal
site of action. Br J Urol 2002;167(1):402-406.
Giuliano F, Hultling C, El Masry W S et al.
Randomized trial of sildenafil for the treatment of
erectile dysfunction in spinal cord injury. Sildenafil
Study Group. Ann Neurol. 1999;46(1):15-21.
Giuliano F, Pena B M, Mishra A et al. Efficacy results
and quality-of-life measures in men receiving
sildenafil citrate for the treatment of erectile
dysfunction. Qual Life Res 2001;10(4):359-369.
Giuliano Francois, Pena Beatrice, Mishra Avanish et
al. "Efficacy results and quality-of-life measures in
men receiving sildenafil citrate for the treatment of
erectile dysfunction": Erratum. Quality of Life
Research: An International Journal of Quality of Life
Aspects of Treatment, Care & Rehabilitation
2002;11(6):613-670.
Gladh Y M, Rahgozar M, Hammar M L et al.
Prevalence of symptoms possibly related to PADAM,
in a Swedish population aged 55, 65 and 75 years.
Maturitas 2005;50(3):161-166.
Glasser S P. Revisiting erectile dysfunction in
cardiovascular patients. Cardiology Review
2003;20(12):42-43.
D-134